Vendor description
This vendor hasn't published their own description yet. It will appear here once they claim this profile and add it from their dashboard.
At a glance
- Oncology-focused RWE company using the COTA Grading System to classify cancer patients into clinically relevant subgroups for real-world evidence generation.
- Coverage: North America · Phase II–IV
- Therapeutic focus: Oncology, Hematology
- Scale: Small,Medium
Company fit
Best suited for
Oncology RWE,Patient classification,Real-world outcomes analysis
Study fit
Niche oncology RWE provider with unique patient grading methodology for more precise real-world cohorts.
Core strengths
- Proprietary COTA Grading System
- Oncology specialism
- Clinically relevant cohorts
Considerations
- Oncology/hematology only
- Small company
Key facts
- Category
- Biometrics / data science
- Geography
- North America
- Service model
- SaaS + Data
- Vendor type
- Technology
- HQ
- United States